01801 信达生物
按盘价 
37.700 -0.050 (-0.132%) | 2022/12 - 末期 人民币(千) | 与去年末期 比较 | 2021/12 人民币(千) | 2020/12 人民币(千) | 2019/12 人民币(千) | 2018/12 人民币(千) |
非流动资产
| 投资物业 | 0 | -- | 0 | 0 | 0 | 0 |
| 物业、厂房、设备及其他 | 3,411,496 | 26.681% | 2,692,986 | 1,584,079 | 1,344,788 | 1,078,053 |
| 租賃土地 | 414,650 | 4.482% | 396,862 | 327,124 | 91,516 | 52,842 |
| 无形资产 | 1,198,163 | 55.163% | 772,194 | 32,625 | 0 | 0 |
| 联营公司及共同控制公司权益 | 0 | -- | 0 | 0 | 0 | 0 |
| 其他非流动资产 | 1,057,828 | 27.323% | 830,822 | 424,487 | 338,802 | 295,421 |
| 6,082,137 | 29.604% | 4,692,864 | 2,368,315 | 1,775,106 | 1,426,316 |
流动资产
| 存货 | 1,428,882 | 6.060% | 1,347,240 | 705,658 | 358,597 | 66,121 |
| 现金及银行结存 | 9,162,823 | 9.379% | 8,377,095 | 7,763,833 | 4,232,642 | 4,525,352 |
| 其他流动资产 | 915,003 | -49.904% | 1,826,514 | 997,190 | 864,184 | 94,788 |
| 持作出售资产 | 0 | -- | 0 | 0 | 0 | 0 |
| 11,506,708 | -0.382% | 11,550,849 | 9,466,681 | 5,455,423 | 4,686,261 |
流动负债
| 其他流动负债 | 3,499,198 | 14.726% | 3,050,047 | 1,485,851 | 1,043,556 | 670,321 |
| 持作出售资产相关负债 | 0 | -- | 0 | 0 | 0 | 0 |
| 3,499,198 | 14.726% | 3,050,047 | 1,485,851 | 1,043,556 | 670,321 | |
| 流动资产净值 | 8,007,510 | -5.803% | 8,500,802 | 7,980,830 | 4,411,867 | 4,015,940 |
| 资产总额减流动负债 | 14,089,647 | 6.791% | 13,193,666 | 10,349,145 | 6,186,973 | 5,442,256 |
非流动负债
| 3,359,698 | 17.338% | 2,863,269 | 1,569,375 | 1,430,842 | 1,247,842 |
资本及储备
| 股本 | 105 | 3.960% | 101 | 97 | 87 | 79 |
| 储备 | 10,729,844 | 3.868% | 10,330,296 | 8,779,673 | 4,756,044 | 4,194,335 |
| 其他 | 0 | -- | 0 | 0 | 0 | 0 |
| 股东资金 | 10,729,949 | 3.868% | 10,330,397 | 8,779,770 | 4,756,131 | 4,194,414 |
| 非控股权益 | 0 | -- | 0 | 0 | 0 | 0 |
| 其他 | 0 | -- | 0 | 0 | 0 | 0 |
| 10,729,949 | 3.868% | 10,330,397 | 8,779,770 | 4,756,131 | 4,194,414 |
承担及或然负债
| 承担 | -- | -- | 1,647,517 | 731,142 | 94,394 | 134,249 |
| 或然负债 | -- | -- | 0 | 0 | 0 | 0 |
| 备注： | 实时报价更新时间为29/05/2023 09:57 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) (千) | RMB -2,179,270 |
| 增长率 | -20.137% |
| 每股盈利/(亏损) | RMB -1.460 |
| 每股账面资产净值 (¥) | RMB 6.993 |